Other inhibitors
| Cat. No. | Product Name | Inquiry |
|---|---|---|
| X24-09-YM1335 | (Z)-2-decenoic acid, Purity ≥98% | |
| X24-09-YM1337 | Benfotiamine, Purity ≥98% | |
| X24-09-YM1338 | Deferasirox Fe3+ chelate, Purity ≥98% | |
| X24-09-YM1339 | EBE-A22, Purity ≥98% | |
| X24-09-YM1340 | Etimizol, Purity ≥98% | |
| X24-09-YM1342 | Pafuramidine, Purity ≥98% | |
| X24-09-YM1343 | Pamabrom, Purity ≥98% | |
| X24-09-YM1344 | Retinyl glucoside, Purity ≥98% | |
| X24-09-YM1345 | Sodium 4-pentynoate, Purity ≥98% | |
| X24-09-YM1346 | Sodium formononetin-3'-sulfonate, Purity ≥98% | |
| X24-09-YM1347 | DAPK substrate peptide, Purity ≥98% | |
| X24-09-YM1348 | Beta-lipotropin (1-10), porcine, Purity ≥98% | |
| X24-09-YM1349 | 2-Hexadecenoic acid, Purity ≥98% | |
| X24-09-YM1350 | SKQ1 Bromide, Purity ≥98% | |
| X24-09-YM1351 | Finafloxacin hydrochloride, Purity ≥98% | |
| X24-09-YM1352 | NSC-41589, Purity ≥98% | |
| X24-09-YM1353 | Bucetin, Purity ≥98% | |
| X24-09-YM1354 | WST-8, Purity ≥98% | |
| X24-09-YM1356 | 21-Norrapamycin, Purity ≥98% | |
| X24-09-YM1357 | UNC1079, Purity ≥98% |
